cabozantinib,atezolizumab
roche
['contact03']
#asco23 happening now! much awaited #contact03 - first phase 3 trial evaluating the efficacy of pdli on or after i/o - similar pfs and os in both arms 
Medical Director of GU Medical Oncology, Assistant Professor @UCSF with focus on #KidneyCancer. Alum of @UChicago. RTs not endorsements